Anzeige
Mehr »
Montag, 01.09.2025 - Börsentäglich über 12.000 News
Blockbuster-Potenzial und Übernahmefantasie: Hier entsteht das nächste Big Pharma-Ziel!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
01.09.25 | 08:14
6,400 Euro
0,00 % 0,000
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
6,4006,60022:06
6,3506,65020:59

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
19.08.Does LifeCore (LFCR) Have a High Expected Value?1
18.08.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
07.08.Lifecore Biomedical GAAP EPS of -$0.06 beats by $0.04, revenue of $36.4M beats by $1.04M1
07.08.LIFECORE BIOMEDICAL, INC. \DE\ - S-8, Securities to be offered to employees in employee benefit plans1
07.08.LIFECORE BIOMEDICAL, INC. \DE\ - 10-K, Annual Report1
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
07.08.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
07.08.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update96-- Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook -- -- Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting...
► Artikel lesen
31.07.Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 20251
18.07.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report2
17.07.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)83CHASKA, Minn., July 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore") a fully integrated contract development and manufacturing organization ("CDMO"), today announced...
► Artikel lesen
18.06.Lifecore Signs 10-Year Manufacturing Deal To Support Novel Ophthalmic Therapy-
17.06.Lifecore Biomedical Enters 10-Year Commercial Manufacturing & Supply Agreement with Existing Customer1
17.06.Lifecore Biomedical signs new 10-year commercial manufacturing and supply agreement2
17.06.Lifecore signs 10-year manufacturing deal with key ophthalmic client1
17.06.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer1
17.06.Lifecore Biomedical Q3 2025 slides: Revenue dip amid ambitious growth strategy1
12.06.Lifecore Receives Full Payment Early For $17 Mln Equipment Sale3
12.06.Lifecore Biomedical receives accelerated payment of remaining $10M in proceeds from equipment sale1
12.06.Lifecore erhält vorzeitige Zahlung von 10 Millionen US-Dollar für Anlagenverkauf3
12.06.Lifecore Biomedical, Inc.: Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale146CHASKA, Minn., June 12, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced...
► Artikel lesen
Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1